The global Endocannabinoid System Targeted Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Endocannabinoid System Targeted Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endocannabinoid System Targeted Therapeutics.

Report Scope

The Endocannabinoid System Targeted Therapeutics market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Endocannabinoid System Targeted Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Endocannabinoid System Targeted Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Endocannabinoid System Targeted Therapeutics Market Report

Report Metric	Details
Report Name	Endocannabinoid System Targeted Therapeutics Market
CAGR	5%
Segment by Type	Oral Inhalation Others
Segment by Application	Autoimmune Disorders Genetic Disorders Neurological Disorders Pain Disorders
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GW Pharmaceuticals, MAKScientific, Corbus Pharmaceuticals, Tilray, Pure Green, Avicanna, GB Sciences, Botanix Pharmaceuticals, Therapix Biosciences, Zelira Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Endocannabinoid System Targeted Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Endocannabinoid System Targeted Therapeutics Market report?

Ans: The main players in the Endocannabinoid System Targeted Therapeutics Market are GW Pharmaceuticals, MAKScientific, Corbus Pharmaceuticals, Tilray, Pure Green, Avicanna, GB Sciences, Botanix Pharmaceuticals, Therapix Biosciences, Zelira Therapeutics

What are the Application segmentation covered in the Endocannabinoid System Targeted Therapeutics Market report?

Ans: The Applications covered in the Endocannabinoid System Targeted Therapeutics Market report are Autoimmune Disorders, Genetic Disorders, Neurological Disorders, Pain Disorders

What are the Type segmentation covered in the Endocannabinoid System Targeted Therapeutics Market report?

Ans: The Types covered in the Endocannabinoid System Targeted Therapeutics Market report are Oral, Inhalation, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Oral

1.2.3 Inhalation

1.2.4 Others

1.3 Market by Application

1.3.1 Global Endocannabinoid System Targeted Therapeutics Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Autoimmune Disorders

1.3.3 Genetic Disorders

1.3.4 Neurological Disorders

1.3.5 Pain Disorders

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Endocannabinoid System Targeted Therapeutics Market Perspective (2019-2030)

2.2 Endocannabinoid System Targeted Therapeutics Growth Trends by Region

2.2.1 Global Endocannabinoid System Targeted Therapeutics Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Endocannabinoid System Targeted Therapeutics Historic Market Size by Region (2019-2024)

2.2.3 Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Region (2025-2030)

2.3 Endocannabinoid System Targeted Therapeutics Market Dynamics

2.3.1 Endocannabinoid System Targeted Therapeutics Industry Trends

2.3.2 Endocannabinoid System Targeted Therapeutics Market Drivers

2.3.3 Endocannabinoid System Targeted Therapeutics Market Challenges

2.3.4 Endocannabinoid System Targeted Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue

3.1.1 Global Top Endocannabinoid System Targeted Therapeutics Players by Revenue (2019-2024)

3.1.2 Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Players (2019-2024)

3.2 Global Endocannabinoid System Targeted Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Endocannabinoid System Targeted Therapeutics Revenue

3.4 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio

3.4.1 Global Endocannabinoid System Targeted Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Endocannabinoid System Targeted Therapeutics Revenue in 2023

3.5 Endocannabinoid System Targeted Therapeutics Key Players Head office and Area Served

3.6 Key Players Endocannabinoid System Targeted Therapeutics Product Solution and Service

3.7 Date of Enter into Endocannabinoid System Targeted Therapeutics Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Endocannabinoid System Targeted Therapeutics Breakdown Data by Type

4.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Type (2019-2024)

4.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2025-2030)

5 Endocannabinoid System Targeted Therapeutics Breakdown Data by Application

5.1 Global Endocannabinoid System Targeted Therapeutics Historic Market Size by Application (2019-2024)

5.2 Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Endocannabinoid System Targeted Therapeutics Market Size (2019-2030)

6.2 North America Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2019-2024)

6.4 North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Endocannabinoid System Targeted Therapeutics Market Size (2019-2030)

7.2 Europe Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2019-2024)

7.4 Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size (2019-2030)

8.2 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2019-2024)

8.4 Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Endocannabinoid System Targeted Therapeutics Market Size (2019-2030)

9.2 Latin America Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2019-2024)

9.4 Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size (2019-2030)

10.2 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2019-2024)

10.4 Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GW Pharmaceuticals

11.1.1 GW Pharmaceuticals Company Detail

11.1.2 GW Pharmaceuticals Business Overview

11.1.3 GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction

11.1.4 GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

11.1.5 GW Pharmaceuticals Recent Development

11.2 MAKScientific

11.2.1 MAKScientific Company Detail

11.2.2 MAKScientific Business Overview

11.2.3 MAKScientific Endocannabinoid System Targeted Therapeutics Introduction

11.2.4 MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

11.2.5 MAKScientific Recent Development

11.3 Corbus Pharmaceuticals

11.3.1 Corbus Pharmaceuticals Company Detail

11.3.2 Corbus Pharmaceuticals Business Overview

11.3.3 Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction

11.3.4 Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

11.3.5 Corbus Pharmaceuticals Recent Development

11.4 Tilray

11.4.1 Tilray Company Detail

11.4.2 Tilray Business Overview

11.4.3 Tilray Endocannabinoid System Targeted Therapeutics Introduction

11.4.4 Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

11.4.5 Tilray Recent Development

11.5 Pure Green

11.5.1 Pure Green Company Detail

11.5.2 Pure Green Business Overview

11.5.3 Pure Green Endocannabinoid System Targeted Therapeutics Introduction

11.5.4 Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

11.5.5 Pure Green Recent Development

11.6 Avicanna

11.6.1 Avicanna Company Detail

11.6.2 Avicanna Business Overview

11.6.3 Avicanna Endocannabinoid System Targeted Therapeutics Introduction

11.6.4 Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

11.6.5 Avicanna Recent Development

11.7 GB Sciences

11.7.1 GB Sciences Company Detail

11.7.2 GB Sciences Business Overview

11.7.3 GB Sciences Endocannabinoid System Targeted Therapeutics Introduction

11.7.4 GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

11.7.5 GB Sciences Recent Development

11.8 Botanix Pharmaceuticals

11.8.1 Botanix Pharmaceuticals Company Detail

11.8.2 Botanix Pharmaceuticals Business Overview

11.8.3 Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Introduction

11.8.4 Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

11.8.5 Botanix Pharmaceuticals Recent Development

11.9 Therapix Biosciences

11.9.1 Therapix Biosciences Company Detail

11.9.2 Therapix Biosciences Business Overview

11.9.3 Therapix Biosciences Endocannabinoid System Targeted Therapeutics Introduction

11.9.4 Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

11.9.5 Therapix Biosciences Recent Development

11.10 Zelira Therapeutics

11.10.1 Zelira Therapeutics Company Detail

11.10.2 Zelira Therapeutics Business Overview

11.10.3 Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Introduction

11.10.4 Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

11.10.5 Zelira Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

GW Pharmaceuticals

MAKScientific

Corbus Pharmaceuticals

Botanix Pharmaceuticals

Therapix Biosciences

Zelira Therapeutics

List of Tables

Table 1. Global Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Oral

Table 3. Key Players of Inhalation

Table 4. Key Players of Others

Table 5. Global Endocannabinoid System Targeted Therapeutics Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Endocannabinoid System Targeted Therapeutics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Endocannabinoid System Targeted Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Endocannabinoid System Targeted Therapeutics Market Share by Region (2019-2024)

Table 9. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Endocannabinoid System Targeted Therapeutics Market Share by Region (2025-2030)

Table 11. Endocannabinoid System Targeted Therapeutics Market Trends

Table 12. Endocannabinoid System Targeted Therapeutics Market Drivers

Table 13. Endocannabinoid System Targeted Therapeutics Market Challenges

Table 14. Endocannabinoid System Targeted Therapeutics Market Restraints

Table 15. Global Endocannabinoid System Targeted Therapeutics Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Endocannabinoid System Targeted Therapeutics Market Share by Players (2019-2024)

Table 17. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2023)

Table 18. Ranking of Global Top Endocannabinoid System Targeted Therapeutics Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Endocannabinoid System Targeted Therapeutics Product Solution and Service

Table 22. Date of Enter into Endocannabinoid System Targeted Therapeutics Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Endocannabinoid System Targeted Therapeutics Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2019-2024)

Table 26. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Type (2025-2030)

Table 28. Global Endocannabinoid System Targeted Therapeutics Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2019-2024)

Table 30. Global Endocannabinoid System Targeted Therapeutics Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Endocannabinoid System Targeted Therapeutics Revenue Market Share by Application (2025-2030)

Table 32. North America Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Endocannabinoid System Targeted Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Endocannabinoid System Targeted Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Endocannabinoid System Targeted Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size by Country (2025-2030) & (US$ Million)

Table 47. GW Pharmaceuticals Company Detail

Table 48. GW Pharmaceuticals Business Overview

Table 49. GW Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product

Table 50. GW Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024) & (US$ Million)

Table 51. GW Pharmaceuticals Recent Development

Table 52. MAKScientific Company Detail

Table 53. MAKScientific Business Overview

Table 54. MAKScientific Endocannabinoid System Targeted Therapeutics Product

Table 55. MAKScientific Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024) & (US$ Million)

Table 56. MAKScientific Recent Development

Table 57. Corbus Pharmaceuticals Company Detail

Table 58. Corbus Pharmaceuticals Business Overview

Table 59. Corbus Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product

Table 60. Corbus Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024) & (US$ Million)

Table 61. Corbus Pharmaceuticals Recent Development

Table 62. Tilray Company Detail

Table 63. Tilray Business Overview

Table 64. Tilray Endocannabinoid System Targeted Therapeutics Product

Table 65. Tilray Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024) & (US$ Million)

Table 66. Tilray Recent Development

Table 67. Pure Green Company Detail

Table 68. Pure Green Business Overview

Table 69. Pure Green Endocannabinoid System Targeted Therapeutics Product

Table 70. Pure Green Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024) & (US$ Million)

Table 71. Pure Green Recent Development

Table 72. Avicanna Company Detail

Table 73. Avicanna Business Overview

Table 74. Avicanna Endocannabinoid System Targeted Therapeutics Product

Table 75. Avicanna Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024) & (US$ Million)

Table 76. Avicanna Recent Development

Table 77. GB Sciences Company Detail

Table 78. GB Sciences Business Overview

Table 79. GB Sciences Endocannabinoid System Targeted Therapeutics Product

Table 80. GB Sciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024) & (US$ Million)

Table 81. GB Sciences Recent Development

Table 82. Botanix Pharmaceuticals Company Detail

Table 83. Botanix Pharmaceuticals Business Overview

Table 84. Botanix Pharmaceuticals Endocannabinoid System Targeted Therapeutics Product

Table 85. Botanix Pharmaceuticals Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024) & (US$ Million)

Table 86. Botanix Pharmaceuticals Recent Development

Table 87. Therapix Biosciences Company Detail

Table 88. Therapix Biosciences Business Overview

Table 89. Therapix Biosciences Endocannabinoid System Targeted Therapeutics Product

Table 90. Therapix Biosciences Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024) & (US$ Million)

Table 91. Therapix Biosciences Recent Development

Table 92. Zelira Therapeutics Company Detail

Table 93. Zelira Therapeutics Business Overview

Table 94. Zelira Therapeutics Endocannabinoid System Targeted Therapeutics Product

Table 95. Zelira Therapeutics Revenue in Endocannabinoid System Targeted Therapeutics Business (2019-2024) & (US$ Million)

Table 96. Zelira Therapeutics Recent Development

Table 97. Research Programs/Design for This Report

Table 98. Key Data Information from Secondary Sources

Table 99. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Endocannabinoid System Targeted Therapeutics Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Endocannabinoid System Targeted Therapeutics Market Share by Type: 2023 VS 2030

Figure 3. Oral Features

Figure 4. Inhalation Features

Figure 5. Others Features

Figure 6. Global Endocannabinoid System Targeted Therapeutics Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Endocannabinoid System Targeted Therapeutics Market Share by Application: 2023 VS 2030

Figure 8. Autoimmune Disorders Case Studies

Figure 9. Genetic Disorders Case Studies

Figure 10. Neurological Disorders Case Studies

Figure 11. Pain Disorders Case Studies

Figure 12. Endocannabinoid System Targeted Therapeutics Report Years Considered

Figure 13. Global Endocannabinoid System Targeted Therapeutics Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Endocannabinoid System Targeted Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Endocannabinoid System Targeted Therapeutics Market Share by Region: 2023 VS 2030

Figure 16. Global Endocannabinoid System Targeted Therapeutics Market Share by Players in 2023

Figure 17. Global Top Endocannabinoid System Targeted Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endocannabinoid System Targeted Therapeutics as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Endocannabinoid System Targeted Therapeutics Revenue in 2023

Figure 19. North America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Endocannabinoid System Targeted Therapeutics Market Share by Country (2019-2030)

Figure 21. United States Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Endocannabinoid System Targeted Therapeutics Market Share by Country (2019-2030)

Figure 25. Germany Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Endocannabinoid System Targeted Therapeutics Market Share by Region (2019-2030)

Figure 33. China Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Endocannabinoid System Targeted Therapeutics Market Share by Country (2019-2030)

Figure 41. Mexico Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Endocannabinoid System Targeted Therapeutics Market Share by Country (2019-2030)

Figure 45. Turkey Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Endocannabinoid System Targeted Therapeutics Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. GW Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

Figure 48. MAKScientific Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

Figure 49. Corbus Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

Figure 50. Tilray Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

Figure 51. Pure Green Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

Figure 52. Avicanna Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

Figure 53. GB Sciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

Figure 54. Botanix Pharmaceuticals Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

Figure 55. Therapix Biosciences Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

Figure 56. Zelira Therapeutics Revenue Growth Rate in Endocannabinoid System Targeted Therapeutics Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-31X2542

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

ELISA Technologies - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-6C4296

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Blow-Fill-Seal (BFS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-22N3952

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

Membrane Technology in Pharma, Biopharma, And Life Science - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5A6999

Thu Oct 10 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Endocannabinoid System Targeted Therapeutics Market Research Report 2024

Published Date: June 2024

Report Code: QYRE-Auto-13P13788

Global Endocannabinoid System Targeted Therapeutics Market Research Report 2024

FEATURED COMPANIES

Endocannabinoid System Targeted Therapeutics Market Size

Endocannabinoid System Targeted Therapeutics Market

Report Scope

Scope of Endocannabinoid System Targeted Therapeutics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Endocannabinoid System Targeted Therapeutics Market report?

What are the Application segmentation covered in the Endocannabinoid System Targeted Therapeutics Market report?

What are the Type segmentation covered in the Endocannabinoid System Targeted Therapeutics Market report?

FEATURED COMPANIES

RELATED REPORTS